3SBio Inc. to Present at the Merrill Lynch Global Pharmaceutical, Biotechnology and Medical Device Conference

SHENYANG, China, Jan. 30 3SBio Inc.(Nasdaq: SSRX), a leading China-based biotechnology company focused onresearching, developing, manufacturing and marketing biopharmaceuticalproducts, announces today that David Chen, VP of Business Development, willpresent at the Merrill Lynch Global Pharmaceutical, Biotechnology and MedicalDevice Conference at The Grand Hyatt hotel in New York on Tuesday, February 5,2008 at 11:00 A.M. (Eastern).

The presentation will be audio webcast live and can be accessed on theEvents section of the investors page of the 3SBio website athttp://bbs.3sbio.com/en/News/ShowInfo_nnn6.aspx?ID=65 . A replay of thepresentation and accompanying slides will be available on the 3SBio websiteuntil February 19, 2008.

About 3SBio Inc.

3SBio Inc. is a leading, fully integrated biotechnology company focused onresearching, developing, manufacturing and marketing biopharmaceuticalproducts, primarily in China. For more information, please visit 3SBio on theweb at http://www.3sbio.com .For more information, please contact: Investor Contact: Kevin Teo, CFO 3SBio Inc. Tel: +86-24-2581-1820 Investor Relations(HK): Ruby Yim Taylor Rafferty Tel: +852-3196-3712 Investor Relations(US): Mahmoud Siddig Taylor Rafferty Tel: +1-212-889-4350 Media Contact: John Dooley Taylor Rafferty Tel: +1-212-889-4350

SOURCE 3SBio Inc.

Latest Press Release on General News

Precision oncology company Flindr Therapeutics announces €20 million Series A financing to advance first-in-class small molecule inhibitors

V-Bio Ventures leads international syndicate which includes Johnson & Johnson Innovation – JJDC, Inc., QBIC Fund, Flanders Future Tech Fund, Curie Capital as well as seed investor...

Rett Syndrome Research Trust Partners with Vivalink to Shift Symptom Assessment Paradigms in Rett Syndrome

Vivalink's remote patient monitoring solutions accelerate research into rare neurological disorder CAMPBELL, Calif. , April 23, 2024 /PRNewswire/ -- Vivalink , a leading pro...

World IBS Day - April 19th: Raising Awareness for Everyone with IBS

Debunking myths about Irritable Bowel Syndrome TORONTO , April 18, 2024 /PRNewswire/ -- IBS is a chronic gastrointestinal disorder with symptoms like abdominal pain, bloating,...

Important step taken on the Canada Disability Benefit in Budget 2024, but funding falls short

More work must be done to lift Canadians with disabilities out of poverty TORONTO , April 17, 2024 /CNW/ - The federal government has taken an important step on the Canada Di...

Hydrinity Accelerated Skin Science Introduces MicroFusion Technology and Expands Facial Skincare Line with PRELUDE Facial Treatment Cleanser and HYDRI-C Vitamin C Moisturizer

The Next Generation Technology with the Power to Transform Skin MONROE, La. , April 15, 2024 /PRNewswire/ -- Hydrinity Accelerated Skin Science announced today the launch of t...